Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03073980 · ClinicalTrials.gov registry record · Phase 4
Assessing Efficacy of Intravenous Acetaminophen for Perioperative Pain Control for Oocyte Retrieval
A Phase 4 study of Pain, Postoperative and Infertility, Female, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 161
- Enrollment target
- 1
- Study location
NCT03073980: Completed Phase 4 study of Pain, Postoperative and Infertility, Female, sponsored by Massachusetts General Hospital.
NCT03073980 is a Phase 4 study of Pain, Postoperative and Infertility, Female that has completed, run by Massachusetts General Hospital. The registered enrollment target is 161 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03073980, a Phase 4 study of Pain, Postoperative and Infertility, Female, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 161 participants
- Enrollment target
- 1
- Study location
Study Summary
In this research study we want to learn more about how effective certain medications are at reducing pain after oocyte (egg) retrieval surgery and how effective they are at reducing the time between the retrieval and discharge from the hospital. We will compare three types of pre-operative medications: intravenous (IV) acetaminophen, oral (PO) acetaminophen, and placebo (no medication), which is the current typical care.
Primary Outcome
Visual analog scale of pain, ranging from 0 (no pain) to 10 (worst pain imaginable) in whole numbers. The final score is the post-operative score minus the pre-operative score.
Conditions Studied
Interventions
- DRUG IV Acetaminophen
- DRUG PO Acetaminophen
- OTHER Placebo IV Acetaminophen
- OTHER Placebo PO Acetaminophen
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2020-12-01 |
| Phase | Phase 4 |
What the finished NCT03073980 record still lists
NCT03073980 is an interventional study that assigns participants to a tested intervention. The registered 161 participants enrollment target is mid-sized for trials with a published cap, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (41% lower).
The record links to 2 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 4 interventions - of which IV Acetaminophen is the first listed.
NCT03073980 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03073980 about?
NCT03073980 is a clinical study titled "Assessing Efficacy of Intravenous Acetaminophen for Perioperative Pain Control for Oocyte Retrieval". In this research study we want to learn more about how effective certain medications are at reducing pain after oocyte (egg) retrieval surgery and how effective they are at reducing the time between the retrieval and discharge from the hospital. We will compare three types of pre-operative medicatio...
What is the current status of trial NCT03073980?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 161 participants. The study started on 2019-09-01. Estimated completion is 2020-12-01.
What conditions does trial NCT03073980 study?
This clinical trial studies the following conditions: Pain, Postoperative, Infertility, Female.
What interventions are being tested in trial NCT03073980?
The interventions under investigation include: IV Acetaminophen (DRUG), PO Acetaminophen (DRUG), Placebo IV Acetaminophen (OTHER), Placebo PO Acetaminophen (OTHER).
Who is sponsoring clinical trial NCT03073980?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03073980 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03073980's enrollment target sits among peer trials
161 23rd of 113 higher than 91 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
RECRUITING · Phase 4
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
RECRUITING · Phase 4
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
IPACK on Early Pain Scores After ACL Reconstruction
RECRUITING · Phase 4
-
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06391034 · 161 participants · Phase 2
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
- NCT06546670 · 161 participants · Phase 1
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- NCT06616766 · 161 participants · Phase 1
A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
- NCT06752356 · 161 participants · Phase 3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI